Search research articles
Contact Us
Filters
Showing results (301-310 of 455) with videos related to
Page
of 46
Sort By:
Diabetes, Obesity & Metabolism
|
March 27, 2026
Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real-World: Results From the SCORE-Clinical ASCVD Study
Michael G Nanna, Carlos Mena-Hurtado, Victoria Divino, et al.
Diabetes, Obesity & Metabolism
|
October 8, 2016
Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes
P Mensberg, S Nyby, P G Jørgensen, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 29, 2016
Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake
B Guiastrennec, D P Sonne, M Hansen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
October 4, 2017
Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes
Nicolai J Wewer Albrechtsen, Anders E Junker, Mette Christensen, et al.
Diabetes, Obesity & Metabolism
|
June 1, 2026
Acute GIP and GLP-1 Administration Exerts Differential Metabolic Effects in Totally Pancreatectomised Individuals
Liva S L Krogh, Maja B Hansen, Natasha C Bergmann, et al.
Diabetes
|
December 27, 2021
Glucagon Clearance is Preserved in Type 2 Diabetes
Magnus F G Grøndahl, Asger Lund, Jonatan I Bagger, et al.
Diabetes
|
October 27, 2021
Glucagon Clearance is Preserved in Type 2 Diabetes
Magnus F G Grøndahl, Asger Lund, Jonatan I Bagger, et al.
Diabetes, Obesity & Metabolism
|
July 1, 2022
The effect of curcumin on hepatic fat content in individuals with obesity
Pernille H Hellmann, Jonatan I Bagger, Katrine R Carlander, et al.
Endocrine Connections
|
September 14, 2019
Gluco-metabolic effects of oral and intravenous alcohol administration in men
Amalie R Lanng, Lærke S Gasbjerg, Natasha C Bergmann, et al.
Endocrine Reviews
|
March 29, 2019
The Liver-α-Cell Axis and Type 2 Diabetes
Nicolai J Wewer Albrechtsen, Jens Pedersen, Katrine D Galsgaard, et al.
Page
of 46
Search research articles
Search
Showing results (301-310 of 455) with videos related to
Sort By:
Page
of 46
Diabetes, Obesity & Metabolism
|
March 27, 2026
Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real-World: Results From the SCORE-Clinical ASCVD Study
Michael G Nanna, Carlos Mena-Hurtado, Victoria Divino, et al.
Diabetes, Obesity & Metabolism
|
October 8, 2016
Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes
P Mensberg, S Nyby, P G Jørgensen, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 29, 2016
Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake
B Guiastrennec, D P Sonne, M Hansen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
October 4, 2017
Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes
Nicolai J Wewer Albrechtsen, Anders E Junker, Mette Christensen, et al.
Diabetes, Obesity & Metabolism
|
June 1, 2026
Acute GIP and GLP-1 Administration Exerts Differential Metabolic Effects in Totally Pancreatectomised Individuals
Liva S L Krogh, Maja B Hansen, Natasha C Bergmann, et al.
Diabetes
|
December 27, 2021
Glucagon Clearance is Preserved in Type 2 Diabetes
Magnus F G Grøndahl, Asger Lund, Jonatan I Bagger, et al.
Diabetes
|
October 27, 2021
Glucagon Clearance is Preserved in Type 2 Diabetes
Magnus F G Grøndahl, Asger Lund, Jonatan I Bagger, et al.
Diabetes, Obesity & Metabolism
|
July 1, 2022
The effect of curcumin on hepatic fat content in individuals with obesity
Pernille H Hellmann, Jonatan I Bagger, Katrine R Carlander, et al.
Endocrine Connections
|
September 14, 2019
Gluco-metabolic effects of oral and intravenous alcohol administration in men
Amalie R Lanng, Lærke S Gasbjerg, Natasha C Bergmann, et al.
Endocrine Reviews
|
March 29, 2019
The Liver-α-Cell Axis and Type 2 Diabetes
Nicolai J Wewer Albrechtsen, Jens Pedersen, Katrine D Galsgaard, et al.
Page
of 46